HOXD13 and hepatocellular carcinoma: Hence, our findings imply that patients with a lower sPD-1 level before the initiation of NA treatment should be followed up carefully as a population at higher risk of HCC, despite a report that NA treatment for chronic HBV infection reduces the risk of HCC development2–4.